hammer加速器-hammer加速器官网-hammer锤子官网-hammer加速器

Bioengineering
Biological and Medical Informatics
Biophysics
Chemistry and Chemical Biology
Pharmaceutical Sciences and Pharmacogenomics

QBC catalyzes interactions among students across all five graduate programs.

—Charles Craik, PhD, QBC director

The Quantitative Biosciences Consortium (QBC) brings together under one umbrella five PhD graduate programs at the University of California, San Francisco (UCSF) to advance education and innovative research at the interface of the biological sciences and the quantitative sciences.

Bioengineering (BioE)	Preparing scientists to integrate the biological and engineering sciences to build bold, new solutions to biomedical problems
Biological and Medical Informatics (BMI)	Preparing scientists to harness and apply the power of data to understand the complexities of human biology
Biophysics (BP)	Preparing scientists to reveal the intricacies of living systems through the application of physics and chemistry
Chemistry and Chemical Biology (CCB)	Preparing scientists to explore the molecules in complex living systems and how molecules influence health and disease
Pharmaceutical Sciences and Pharmacogenomics (PSPG)	Preparing independent, creative leaders in the pharmaceutical sciences and in the application of genetics and genomics to the development of safe, effective drugs for patients

The consortium promotes curriculum development and faculty and student engagement in the quantitative biosciences. It provides a common physical space for graduate students across the five programs to meet, discuss, and debate ideas. It helps support the financial needs of graduate students in the quantitative biosciences, thus helping free these students to focus their energies on addressing important biological questions.

QBC gives a strong, unified voice to biological and quantitative sciences graduate education—and research—at UCSF.

Image credits: © Majed and Thor Swift Photography

hammer加速器-hammer加速器官网-hammer锤子官网-hammer加速器

UCSF School of Pharmacy leads in NIH funding for the 40th straight year

Seu fights drug-resistant HIV in Zambia with Sanger sequencing

For UCSF graduate, DACA gives a chance to fight cancer

See all